B-Raf antibody [N2C1], Internal
GTX100913
ApplicationsImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetBRAF
Overview
- SupplierGeneTex
- Product NameB-Raf antibody [N2C1], Internal
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:10000. IHC-P: 1:100-1:1000. IP: 1:100-1:500. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.21 mg/ml
- ConjugateUnconjugated
- Gene ID673
- Target nameBRAF
- Target descriptionB-Raf proto-oncogene, serine/threonine kinase
- Target synonymsB-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1, serine/threonine-protein kinase B-raf, 94 kDa B-raf protein, B-Raf proto-oncogene serine/threonine-protein kinase (p94), B-Raf serine/threonine-protein, murine sarcoma viral (v-raf) oncogene homolog B1, proto-oncogene B-Raf, v-raf murine sarcoma viral oncogene homolog B, v-raf murine sarcoma viral oncogene homolog B1
- HostRabbit
- IsotypeIgG
- Protein IDP15056
- Protein NameSerine/threonine-protein kinase B-raf
- Scientific DescriptionThis gene encodes a protein belonging to the raf/mil family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene are associated with cardiofaciocutaneous syndrome, a disease characterized by heart defects, mental retardation and a distinctive facial appearance. Mutations in this gene have also been associated with various cancers, including non-Hodgkin lymphoma, colorectal cancer, malignant melanoma, thyroid carcinoma, non-small cell lung carcinoma, and adenocarcinoma of lung. A pseudogene, which is located on chromosome X, has been identified for this gene. [provided by RefSeq]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Perphenazine exerts antitumor effects on HUT78 cells through Akt dephosphorylation by protein phosphatase 2A. Tsuji S et al., 2021 Feb, Oncol LettRead more
- BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young. Tateishi K et al., 2020 Aug 18, Acta Neuropathol CommunRead more
- Acquired JHDM1D-BRAF Fusion Confers Resistance to FGFR Inhibition in FGFR2-Amplified Gastric Cancer. Sase H et al., 2018 Oct, Mol Cancer TherRead more
- Mitogen-Activated Protein Kinase Pathway: Genetic Analysis of 95 Adrenocortical Tumors. Rubin B et al., 2015, Cancer InvestRead more


![ICC/IF analysis of MCF-7 (left) and HepG2 (right) cells using GTX83134 B-Raf antibody [1H12]. Green : B-Raf Blue: DRAQ5 fluorescent DNA dye Red: Actin filaments](https://www.genetex.com/upload/website/prouct_img/normal/GTX83134/GTX83134_20170912_ICCIF_w_23061322_685.webp)
![ICC/IF analysis of COS7 cells transiently transfected with B-Raf plasmid using GTX84806 B-Raf antibody [1E2].](https://www.genetex.com/upload/website/prouct_img/normal/GTX84806/GTX84806_1237_ICCIF_w_23061420_392.webp)
![ICC/IF analysis of COS7 cells transiently transfected with B-Raf plasmid using GTX84807 B-Raf antibody [1D2].](https://www.genetex.com/upload/website/prouct_img/normal/GTX84807/GTX84807_1239_ICCIF_w_23061420_886.webp)
![ICC/IF analysis of COS7 cells transiently transfected with B-Raf plasmid using GTX84812 B-Raf antibody [3A7].](https://www.genetex.com/upload/website/prouct_img/normal/GTX84812/GTX84812_1240_ICCIF_w_23061420_336.webp)